[1]
F. A. Warid AL-Laftah, M. Elshafie, D. Alhashimi, and A. Pai, “Pretreatment Clinical Variables Associated With the Response to Intravitreal Bevacisumab (Avastin) Injection In Patients With Persistent Diabetic Macular Edema”, JFacMedBagdad, vol. 52, no. 2, pp. 142–146, Jul. 2010, doi: 10.32007/jfacmedbagdad.5221009.